PTS Diagnostics Announces Leadership Promotions

PTS Diagnostics Announces Leadership Promotions

Strategic promotions bolster international & US sales teams

Indianapolis, IN – November 2, 2016 — PTS Diagnostics, the U.S.-based manufacturer of point-of-care biometric testing devices distributed across the globe, has promoted from within to fill key leadership roles within its Asia, Europe and United States sales organizations.

Steve Riendeau has been promoted to Vice President, Global Sales. In this new role, Mr. Riendeau will be responsible for leading PTS Diagnostics’ international and domestic sales efforts with emphasis on expanding the company’s distribution network in Europe. He has been with PTS Diagnostics since 2007.

John Hurrell, PhD, will serve as President of PTS Diagnostics, Asia Pacific. Dr. Hurrell will work to expand PTS Diagnostics’ presence in Asia with an emphasis on India.

Cliffe Allen will now serve as Vice President of U.S. Sales. He has over 28-years’ experience selling medical diagnostics devices. Mr. Allen will oversee PTS Diagnostics’ U.S. sales organization with emphasis on expanding sales of PTS Diagnostics product portfolio through its network of authorized distributors. He leads a team of nine U.S.-based regional sales representatives.

Cole Davis has been promoted to Regional Sales Director. He will lead the eastern U.S. sales force to expand PTS Diagnostics’ presence among the company’s key segments including biometric screening companies, integrated healthcare delivery networks (IDNs) and physician offices and clinics.

“PTS Diagnostics continues to grow and expand in the U.S. and around the globe,” said Robert Huffstodt, President and CEO of PTS Diagnostics. “By promoting from within, we are able to use our best people to fill key roles on our management team. These individuals, along with the rest of our associates, will work to further expand the sales and clinical adoption of our innovative point-of-care products.”

PTS Diagnostics’ products are manufactured in the United States and marketed globally. The company’s signature products include the CardioChek® family of lipid analyzers, A1CNow® systems and PTS Detect cotinine systems. In addition, the company is now actively marketing its PTS Connect solution, a connectivity and information management platform that increases healthcare professionals’ productivity, and offers population health management capabilities that engage participants to improve their health.

“PTS Diagnostics recently joined the Sinocare family. As a part of a larger organization, these promotions will better position PTS Diagnostics to compete globally and better represent our product portfolio to customers and the growing number of prospects that seek innovate point-ofcare diagnostics products as well as PTS Connect platform. This best-in-class connectivity and information management solution provides a significant competitive advantage for PTS Diagnostics to the healthcare professionals that utilize our products,” said Huffstodt.

About PTS Diagnostics
PTS Diagnostics is an innovative, global, point-of-care diagnostics solutions provider that partners with patients and healthcare professionals to provide the right information at the right time to make the right decisions. The company’s name represents the three pillars upon which it has built its long-term success: People, Technology and Service. Headquartered in Indianapolis, Indiana, PTS Diagnostics designs, manufactures, distributes and markets products for distribution in more than 135 countries around the world. PTS Diagnostics joins Trividia Health to become a member of Sinocare, a biosensor technology company that enables both medical professionals and individuals across the globe to identify, monitor and diagnose chronic diseases at the point of care. For more information, visit www.ptsdiagnostics.com or contact Laura Wilkerson at 317-870-5610 or lwilkerson@ptsdiagnostics.com.

MKG002291 Rev. 0 11/16